<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01076296</url>
  </required_header>
  <id_info>
    <org_study_id>OHSU_Vscan_02</org_study_id>
    <nct_id>NCT01076296</nct_id>
  </id_info>
  <brief_title>A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System</brief_title>
  <official_title>A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to collect data and learn more about the Vscan Ultrasound Imaging System. It is
      an &quot;observational&quot; study with no additional procedures or intervention prescribed other than
      using the Vscan along with a routine medical physical exam.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study requires 2 visits to OHSU.

      At the first visit a cardiac physical exam will be done by a cardiologist.

      At a second visit, a different cardiologist will perform an ultrasound scan (as part of your
      standard of care) using a Vscan Ultrasound System. The first and the second visit may be done
      on the same day depending upon your schedule and if it's convenient for you to stay. The
      total exam time for both the visits, including standard exam and the study device exam will
      be about 45 minutes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Correct Diagnosis</measure>
    <time_frame>2 years</time_frame>
    <description>A comparison of the percentages of correct diagnosis by VSCAN and clinical exam using a McNemar test for matched pairs with ECHO used as the gold standard.</description>
  </primary_outcome>
  <enrollment type="Actual">1000</enrollment>
  <condition>Left Ventricular Dysfunction</condition>
  <condition>Right Ventricular Dysfunction</condition>
  <condition>Pulmonary Hypertension</condition>
  <condition>Heart Valve Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        In-patient and outpatient population of OHSU Division of Cardiovascular Medicine
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  provided signed and dated informed consent and is willing to provide GE Healthcare
             with demographic data, cardiac medical history, information collected as part of the
             study

          -  New patients who have an echocardiogram less than 6 months and patients who will be
             undergoing an echocardiogram as part of their routine clinical care

        Exclusion Criteria:

          -  Pregnant

          -  less than 18 years of age.

          -  unwilling to provide informed Consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjiv Kaul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2010</study_first_submitted>
  <study_first_submitted_qc>February 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2010</study_first_posted>
  <results_first_submitted>December 16, 2015</results_first_submitted>
  <results_first_submitted_qc>February 8, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 7, 2016</results_first_posted>
  <last_update_submitted>February 8, 2016</last_update_submitted>
  <last_update_submitted_qc>February 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
    <mesh_term>Ventricular Dysfunction, Right</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Abnormal Left Ventricle Function</title>
          <description>Subjects assessed for LV function with both VScan and a clinical examination noting an abnormality.</description>
        </group>
        <group group_id="P2">
          <title>Normal Left Ventricle Function</title>
          <description>Subjects assessed for LV function with both VScan and a clinical examination noting no abnormality.</description>
        </group>
        <group group_id="P3">
          <title>Abnormal Right Ventricle Function</title>
          <description>Subjects assessed for RV function with both VScan and a clinical examination noting an abnormality.</description>
        </group>
        <group group_id="P4">
          <title>Normal Right Ventricle Function</title>
          <description>Subjects assessed for RV function with both VScan and a clinical examination noting no abnormality.</description>
        </group>
        <group group_id="P5">
          <title>Pulmonary Hypertension</title>
          <description>Subjects assessed for Pulmonary Hypertension with both VScan and a clinical examination noting the presence of pulmonary hypertension.</description>
        </group>
        <group group_id="P6">
          <title>No Pulmonary Hypertension</title>
          <description>Subjects assessed for Pulmonary Hypertension with both VScan and a clinical examination noting no presence of pulmonary hypertension.</description>
        </group>
        <group group_id="P7">
          <title>Heart Valve Disease</title>
          <description>Subjects assessed for HVD with both VScan and a clinical examination noting the presence of HVD.</description>
        </group>
        <group group_id="P8">
          <title>No Heart Valve Disease</title>
          <description>Subjects assessed for HVD with both VScan and a clinical examination noting no presence of HVD.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="196"/>
                <participants group_id="P3" count="51"/>
                <participants group_id="P4" count="199"/>
                <participants group_id="P5" count="59"/>
                <participants group_id="P6" count="191"/>
                <participants group_id="P7" count="51"/>
                <participants group_id="P8" count="199"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="196"/>
                <participants group_id="P3" count="51"/>
                <participants group_id="P4" count="199"/>
                <participants group_id="P5" count="59"/>
                <participants group_id="P6" count="191"/>
                <participants group_id="P7" count="51"/>
                <participants group_id="P8" count="199"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Total for All Groups Assessed</title>
          <description>Subjects assessed for LV function using both VScan and a clinical examination.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1000"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.9" spread="15.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="656"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="344"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Correct Diagnosis</title>
        <description>A comparison of the percentages of correct diagnosis by VSCAN and clinical exam using a McNemar test for matched pairs with ECHO used as the gold standard.</description>
        <time_frame>2 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Abnormal Left Ventricle Function</title>
            <description>Subjects assessed for LV function with both VScan and a clinical examination noting an abnormality.</description>
          </group>
          <group group_id="O2">
            <title>Normal Left Ventricle Function</title>
            <description>Subjects assessed for LV function with both VScan and a clinical examination noting no abnormality.</description>
          </group>
          <group group_id="O3">
            <title>Abnormal Right Ventricle Function</title>
            <description>Subjects assessed for RV function with both VScan and a clinical examination noting an abnormality.</description>
          </group>
          <group group_id="O4">
            <title>Normal Right Ventricle Function</title>
            <description>Subjects assessed for RV function with both VScan and a clinical examination noting no abnormality.</description>
          </group>
          <group group_id="O5">
            <title>Pulmonary Hypertension</title>
            <description>Subjects assessed for Pulmonary Hypertension function with both VScan and a clinical examination noting the presence of pulmonary hypertension.</description>
          </group>
          <group group_id="O6">
            <title>No Pulmonary Hypertension</title>
            <description>Subjects assessed for Pulmonary Hypertension function with both VScan and a clinical examination noting the no presence of pulmonary hypertension.</description>
          </group>
          <group group_id="O7">
            <title>Heart Valve Disease</title>
            <description>Subjects assessed for Heart Valve Disease function with both VScan and a clinical examination noting the presence of HVD.</description>
          </group>
          <group group_id="O8">
            <title>No Heart Valve Disease</title>
            <description>Subjects assessed for Heart Valve Disease function with both VScan and a clinical examination noting no presence of HVD.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Correct Diagnosis</title>
          <description>A comparison of the percentages of correct diagnosis by VSCAN and clinical exam using a McNemar test for matched pairs with ECHO used as the gold standard.</description>
          <units>percentage of correct diagnosis</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="196"/>
                <count group_id="O3" value="51"/>
                <count group_id="O4" value="199"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="191"/>
                <count group_id="O7" value="51"/>
                <count group_id="O8" value="199"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="45" upper_limit="77"/>
                    <measurement group_id="O2" value="31" lower_limit="23" upper_limit="39"/>
                    <measurement group_id="O3" value="47" lower_limit="26" upper_limit="67"/>
                    <measurement group_id="O4" value="6" lower_limit="1" upper_limit="12"/>
                    <measurement group_id="O5" value="10" lower_limit="8" upper_limit="29"/>
                    <measurement group_id="O6" value="3" lower_limit="3" upper_limit="9"/>
                    <measurement group_id="O7" value="39" lower_limit="19" upper_limit="59"/>
                    <measurement group_id="O8" value="4" lower_limit="2" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Abnormal Left Ventricle Function</title>
          <description>Subjects assessed for LV function with both VScan and a clinical examination noting an abnormality.</description>
        </group>
        <group group_id="E2">
          <title>Normal Left Ventricle Function</title>
          <description>Subjects assessed for LV function with both VScan and a clinical examination noting no abnormality.</description>
        </group>
        <group group_id="E3">
          <title>Abnormal Right Ventricle Function</title>
          <description>Subjects assessed for RV function with both VScan and a clinical examination noting an abnormality.</description>
        </group>
        <group group_id="E4">
          <title>Normal Right Ventricle Function</title>
          <description>Subjects assessed for RV function with both VScan and a clinical examination noting no abnormality.</description>
        </group>
        <group group_id="E5">
          <title>Pulmonary Hypertension</title>
          <description>Subjects assessed for Pulmonary Hypertension with both VScan and a clinical examination noting the presence of pulmonary hypertension.</description>
        </group>
        <group group_id="E6">
          <title>No Pulmonary Hypertension</title>
          <description>Subjects assessed for Pulmonary Hypertension with both VScan and a clinical examination noting no presence of pulmonary hypertension.</description>
        </group>
        <group group_id="E7">
          <title>Heart Valve Disease</title>
          <description>Subjects assessed for HVD with both VScan and a clinical examination noting the presence of HVD.</description>
        </group>
        <group group_id="E8">
          <title>No Heart Valve Disease</title>
          <description>Subjects assessed for HVD with both VScan and a clinical examination noting no presence of HVD.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="196"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="199"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="199"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="54"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="196"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="199"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="199"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Anita Johnson</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>262-548-2825</phone>
      <email>Anita.Johnson@ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

